GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » EBITDA Margin %

Oventus Medical (ASX:OVN) EBITDA Margin % : -807.04% (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Oventus Medical's EBITDA for the six months ended in Dec. 2021 was A$-4.47 Mil. Oventus Medical's Revenue for the six months ended in Dec. 2021 was A$0.55 Mil. Therefore, Oventus Medical's EBITDA margin for the quarter that ended in Dec. 2021 was -807.04%.


Oventus Medical EBITDA Margin % Historical Data

The historical data trend for Oventus Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical EBITDA Margin % Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
EBITDA Margin %
-1,346.88 -1,990.77 -2,225.00 -2,051.07 -777.34

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -2,454.79 -1,722.51 -731.27 -825.79 -807.04

Competitive Comparison of Oventus Medical's EBITDA Margin %

For the Medical Devices subindustry, Oventus Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Oventus Medical's EBITDA Margin % falls into.



Oventus Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Oventus Medical's EBITDA Margin % for the fiscal year that ended in Jun. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2021 )/Revenue (A: Jun. 2021 )
=-8.473/1.09
=-777.34 %

Oventus Medical's EBITDA Margin % for the quarter that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=-4.471/0.554
=-807.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oventus Medical  (ASX:OVN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Oventus Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Oventus Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines